Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI

X Yang, C Hu, Z Xing, Y Lin, Y Su, X Wang, D Cao - European Radiology, 2023 - Springer
Objective Noninvasive detection of molecular status of astrocytoma is of great clinical
significance for predicting therapeutic response and prognosis. We aimed to evaluate …

[HTML][HTML] Current immunotherapeutic approaches for malignant gliomas

MH Han, CH Kim - Brain Tumor Research and Treatment, 2022 - synapse.koreamed.org
Glioblastoma is the most common malignant central nervous system (CNS) tumor (48.3%),
with a median survival of only about 14.6 months. Although the CNS is an immune …

[HTML][HTML] Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma

AA Hareedy, SAM Al Sheikh… - Asian Pacific Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: Programmed death ligand 1 (PD-L1) expression was suggested as a poor
prognostic predictor for glioblastoma. While isocitrate dehydrogenase (IDH) has been linked …

Quantification de l'immunomarquage spécifique par nanoparticules plasmoniques sur lignées cellulaires cancéreuses

G Ortiz - 2022 - publications.polymtl.ca
Le cancer est une maladie extrêmement complexe et les traitements disponibles sont
multiples. L'un d'eux, l'immunothérapie, cible spécifiquement certaines protéines …

[PDF][PDF] Immunoexpression of Nestin and Ki-67 in Astrocytoma in a Single Tertiary Health Care Centre

P Bashir, N Rahat, H Shahzad, A Jalbani, F Siraj… - lumhs.edu.pk
ABSTRACT OBJECTIVE: To evaluate the prognostic significance of Nestin and Ki-67
expression in Astrocytoma across different grades. METHODOLOGY: A retrospective cross …

[引用][C] Computational Probe of an Alkylating Prodrug

LD Gogoi - 2023 - Mizoram University